poison pill

B&N Buyout Bid Is a Bet Against Amazon, Apple

Liberty Media, the conglomerate controlled by John Malone, made a $1 billion bid Thursday to buy Barnes & Noble. The bricks-and-mortar bookstore business is declining everywhere, so for Malone's gamble is to pay off, the Nook will have to gain some ground against Apple's iPad and Amazon's Kindle.

Barnes & Noble Shareholders Rubber-Stamp Poison Pill

Back in September, billionaire Ron Burkle lost his proxy war with Barnes & Noble's board, failing to kill the poison pill that kept him from upping his stake in the company. That made Wednesday's shareholders meeting all but a formality. But what's next for the nation's largest bookseller?

Barnes & Noble Stock Gets Downgraded as Proxy Battle Looms

With less than two weeks to go in the bitter proxy contest between Barnes & Noble founder Leonard Riggio and billionaire Ron Burkle, one key analyst has changed his outlook on the company's stock for the worse and a leading proxy advisory firm has sided with the Riggio camp.

eBay Gets Partial Win in Craigslist Poison Pill Lawsuit

Internet auction giant eBay won't have to swallow Craigslist's poison pill after all, a Delaware Chancery Court ruled on Thursday. The online classified ads giant illegally diluted eBay's equity stake in the company after eBay decided to enter the classified ad market itself.

Icahn Raises Hostile Bid for Lions Gate to $7.50 a Share

Lions Gate Entertainment shares jumped some 12.5% to around $7.30 Tuesday after billionaire activist investor Carl Icahn raised his hostile bid for the studio to $7.50 per share in cash, up from the previous offer of $6.50 a share. Lions Gate's board said it will review the offer.

Barnes & Noble Kicks Off Proxy Fight With Burkle

Barnes & Noble's board has sent a letter to shareholders urging them to vote to rebuff investor Ron Burkle's battle to control the bookseller. The letter is part of annual-meeting materials B&N mailed to shareholders, formally launching its proxy battle.

Ron Burkle, Barnes & Noble Hit a Snag

Barnes & Noble and its second-largest shareholder, billionaire Ron Burkle, appears to be over. The two camps have reached a settlement that would give Burkle three board seats in exchange for dropping his lawsuit against the bookseller.

Barnes & Noble Fights Big Investor in Court

The ongoing battle between Barnes & Noble and its second-largest shareholder, Ron Burkle, has recently escalated. Things have gotten so bad that both sides have now landed in the courtroom.

Burkle Sues Barnes & Noble Over Poison Pill

Billionaire Ron Burkle, founder of Yucaipa Cos., is suing Barnes & Noble in an attempt to derail the "poison pill" measure the bookseller adopted last year to prevent his hostile takeover attempt.

Barnes & Noble Denies Ron Burkle More Stock

Ron Burkle is once again a stockholder scorned, his latest attempt to get a better foothold in Barnes & Noble's stock denied. The book retailer's board responded that "there is absolutely no basis whatsoever for the allegations made."

Don't Expect Barnes & Noble's Pop to Last

Thanks to a surprise move by activist investor Ron Burkle, shares of Barnes & Noble had an unusually exciting day on Tuesday Feb. 2, running up to as high as $21 a share from the previous day's closing price of $18. But don't be fooled. The upswing isn't likely to last long.

An Antidote to Barnes & Nobles' Poison Pill?

When billionaire Ron Burkle went on a Barnes & Noble stock buying spree late last year, the bookseller responded with a "poison pill" measure to prevent a hostile takeover. But another firm's stock buys suggest there's an alliance in the works that may hold the antidote to the poison.